+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028

  • PDF Icon

    Report

  • 192 Pages
  • December 2023
  • Region: Global
  • BCC Research
  • ID: 5412046

This research study analyzes the PCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results are reported. This report includes forecasts by product type, technique, application, and region from 2023 through 2028.

The report also analyzes leading and emerging competitors in the current worldwide PCR market.

Report Includes

  • 49 data tables and 65 additional tables
  • An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technique, application, and region
  • In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
  • Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
  • Discussion of sustainability trends and factors in emerging materials in the PCR market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
  • An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
  • Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
  • Profiles of the leading global players, including F. Hoffmann-LaRoche, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corp.

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • What's New in This Update?
  • Methodology and Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown
Chapter 2 Summary and Highlights
  • Market Outlook
  • Highlights of the PCR Market
Chapter 3 Market Overview
  • Overview
  • Evolution of PCR
  • Principles of PCR
  • Instruments and Components of PCR
  • Instruments
  • Target DNA
  • Primers
  • Enzyme and Enzyme Concentration
  • Buffers
  • Magnesium Concentration
  • Deoxyribonucleoside Triphosphates
  • Traditional vs. Real-Time PCR
  • Design of Primers for PCR
  • Primer Selection
  • Primer Length
  • Melting Temperature
  • Specificity
  • G/C Content
  • 3' End Sequence
  • PCR Quantification Methods
  • Absolute Quantification
  • Relative Quantification
  • Components of Quantitative PCR
  • DNA Binding Dyes
  • Probes in qPCR
  • Controls for qPCR Experiments
Chapter 4 Market Dynamics
  • Market Drivers
  • COVID-19
  • Technology Advancements
  • Growing Demand in Clinical Diagnostics
  • Growth in Genomic and Biomarker Research
  • Robust Demand in Industrial Applications
  • Market Challenges
  • High Investment Cost
  • Lack of Trained Professionals
  • Technical Limitations and Competition from Alternative Technologies
  • Stringent Regulatory Landscape
  • Key Factors, Impact on Market
Chapter 5 Market Breakdown by Technique
  • Market Overview
  • Standard PCR (PCR)
  • Reverse Transcription PCR (RT-PCR)
  • Quantitative Real-Time PCR
  • Quantitative Real-Time PCR (qPCR)
  • Quantitative Real-Time Reverse Transcription PCR (RT-qPCR)
  • Multiplex PCR
  • Digital PCR (dPCR)
  • Other PCR Techniques
  • Nested
  • Touchdown
  • Hot-Start
  • Inverse PCR
  • Market Revenue by Technique
  • Quantitative Real-Time PCR (qPCR and RT-qPCR)
  • Standard PCR
  • Reverse Transcription PCR (RT-PCR)
  • Multiplex PCR
  • Digital PCR (dPCR)
  • Other PCRs
Chapter 6 Market Breakdown by Product
  • Market Overview
  • Global Market for PCR, by Product
  • Instruments
  • Market Overview
  • Market Revenue by Type
  • Market Revenue by Region
  • Reagents and Consumables
  • Market Overview
  • Market Revenue by Type
  • Market Revenue by Region
  • Software and Services
  • Market Overview
  • Market Revenue by Type
  • Market Revenue by Region
Chapter 7 Market Breakdown by Application
  • Overview
  • Basic Research Applications
  • Market Overview
  • Market Revenue by Region
  • Clinical Applications
  • Market Overview
  • Market Revenue by Region
  • Industrial Applications
  • Market Overview
  • Market Revenue by Region
Chapter 8 Market Breakdown by Region
  • Market Overview
  • Market Revenue, by Region
  • North America
  • Market Revenue, by Country
  • Europe
  • Market Revenue, by Country
  • Asia-Pacific
  • Market Revenue, by Country
  • Rest of the World (RoW)
Chapter 9 ESG Development
  • Introduction to ESG
  • Sustainability in PCR Industry: An ESG Perspective
  • Key Environmental Issues
  • Industry ESG Performance Analysis
  • Concluding Remarks
Chapter 10 Emerging Technologies and Developments
  • Overview
  • Digital PCR
  • Multiplex PCR Syndromic Testing
  • Point-of-Care & Decentralization of PCR Testing
  • Isothermal Nucleic Acid Amplification Techniques (INAATs)
  • PCR Automation
Chapter 11 Patent Analysis
  • Patents
  • PubMed
Chapter 12 Competitive Intelligence
  • Overview
  • Instruments
  • Reagents, Consumables, and Accessories
  • Leading players
  • Mergers and Acquisitions
Chapter 13 Company Profiles
  • Abbott
  • Agilent Technologies, Inc.
  • Becton, Dickinson And Co.
  • Biomérieux
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Eppendorf Se
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Hologic
  • Merck Kgaa
  • Qiagen
  • Standard Biotools Inc.
  • Sysmex Inostics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Chapter 14 Appendix: Acronyms
List of Tables
Summary Table: Global Market for PCR, by Technique, Through 2028
Table 1: Traditional vs. Real-Time PCR
Table 2: Advantages and Disadvantages of Dye-Based Detection
Table 3: NGS vs. qPCR: A Detailed Comparison
Table 4: Factors Impacting PCR Market
Table 5: Standard PCR vs. RT-PCR
Table 6: Traditional PCR vs. Real-Time PCR vs. Digital PCR: at a Glance
Table 7: Common PCR Techniques and Their Core Benefits
Table 8: Global Market for PCR, by Technique, Through 2028
Table 9: Global Market for PCR, by Product, Through 2028
Table 10: Global Market for PCR Instruments, by Type, Through 2028
Table 11: Global Market for PCR Instruments, by Region, Through 2028
Table 12: North American Market for PCR Instruments, by Country, Through 2028
Table 13: European Market for PCR Instruments, by Country, Through 2028
Table 14: Asia-Pacific Market for PCR Instruments, by Country, Through 2028
Table 15: Global Market for PCR Reagents and Consumables, by Type, Through 2028
Table 16: Global Market for PCR Reagents and Consumables, by Region, Through 2028
Table 17: North American Market for PCR Reagents and Consumables, by Country, Through 2028
Table 18: European Market for PCR Reagents and Consumables, by Country, Through 2028
Table 19: Asia-Pacific Market for PCR Reagents and Consumables, by Country, Through 2028
Table 20: Global Market for PCR Software and Services, by Type, Through 2028
Table 21: Global Market for PCR Software and Services, by Region, Through 2028
Table 22: North American Market for PCR Software and Services, by Country, Through 2028
Table 23: European Market for PCR Software and Services, by Country, Through 2028
Table 24: Asia-Pacific Market for PCR Software and Services, by Country, Through 2028
Table 25: Global Market for PCR, by Application, Through 2028
Table 26: Global Market for PCR in Basic Research Applications, by Region, Through 2028
Table 27: North American Market for PCR in Basic Research Applications, by Country, Through 2028
Table 28: European Market for PCR in Basic Research Applications, by Country, Through 2028
Table 29: Asia-Pacific Market for PCR in Basic Research Applications, by Country, Through 2028
Table 30: Global Market for PCR in Clinical Applications, by Region, Through 2028
Table 31: North American Market for PCR in Clinical Applications, by Country, Through 2028
Table 32: European Market for PCR in Clinical Applications, by Country, Through 2028
Table 33: Asia-Pacific Market for PCR in Clinical Applications, by Country, Through 2028
Table 34: Common Industrial Uses of PCR Testing
Table 35: Global Market for PCR in Industrial Applications, by Region, Through 2028
Table 36: North American Market for PCR in Industrial Applications, by Country, Through 2028
Table 37: European Market for PCR in Industrial Applications, by Country, Through 2028
Table 38: Asia-Pacific Market for PCR in Industrial Applications, by Country, Through 2028
Table 39: Global Market for PCR, by Region, Through 2028
Table 40: North American Market for PCR, by Country, Through 2028
Table 41: European Market for PCR, by Country, Through 2028
Table 42: Asia-Pacific Market for PCR, by Country, Through 2028
Table 43: Key Environmental Issues in the PCR Industry
Table 44: Key Social and Governance Issues in the PCR Industry
Table 45: Net-Zero GHG Commitments, by Major PCR Companies
Table 46: Global ESG Score for Major PCR Companies, 2022 and 2023
Table 47: Commercial PCR Systems for Near Patient Testing
Table 48: Patents Granted to Major PCR Companies in the U.S. Patent Office
Table 49: PubMed Article Count: “RT-PCR” vs. “qPCR” vs. “dPCR” between 2010-2022
Table 50: Leading Players’ Market Ranking in the PCR Market, 2022
Table 51: Selected Mergers and Acquisitions in PCR Industry, Jan 2021-Aug. 2023
Table 52: Abbott Laboratories: Company Snapshot
Table 53: Abbott Laboratories: Financials, 2022
Table 54: Abbott Laboratories: PCR Product Portfolio
Table 55: Abbott Laboratories: Selected Key Developments, Jan 2021-August 2023
Table 56: Agilent: Company Snapshot
Table 57: Agilent: Financials, 2022
Table 58: Agilent: PCR Product Portfolio
Table 59: Agilent: Selected Key Developments, Jan 2021-August 2023
Table 60: BD: Company Snapshot
Table 61: BD: Financials, 2022
Table 62: BD: PCR Product Portfolio
Table 63: BD: Selected Key Developments, Jan 2021-August 2023
Table 64: bioMérieux S.A.: Company Snapshot
Table 65: bioMérieux: Financials, 2022
Table 66: bioMérieux: PCR Product Portfolio
Table 67: bioMérieux: News/Key Developments, Jan 2021-May 2023
Table 68: Bio-Rad Laboratories Inc.: Company Snapshot
Table 69: Bio-Rad Laboratories Inc.: Financials, 2022
Table 70: Bio-Rad Laboratories Inc.: PCR Product Portfolio
Table 71: Bio-Rad Laboratories Inc.: Selected Key Developments, Jan 2021-August 2023
Table 72: Danaher: Company Snapshot
Table 73: Danaher: Financials, 2022
Table 74: Danaher: PCR Product Portfolio
Table 75: Danaher: News/Key Developments, Jan 2021-May 2023
Table 76: Eppendorf: Company Snapshot
Table 77: Eppendorf: Financials, 2022
Table 78: Eppendorf: PCR Product Portfolio
Table 79: Eppendorf: Selected Key Developments, Jan 2021-August 2023
Table 80: Eurofins Scientific: Company Snapshot
Table 81: Eurofins Scientific: Financials, 2022
Table 82: Eurofins Scientific: PCR Product Portfolio
Table 83: Eurofins Scientific: News/Key Developments, Jan 2021-May 2023
Table 84: Roche: Company Snapshot
Table 85: Roche: Financials, 2022
Table 86: Roche: PCR Product Portfolio
Table 87: Roche: News/Key Developments, Jan 2021-May 2023
Table 88: Hologic: Company Snapshot
Table 89: Hologic: Financials, 2022
Table 90: Hologic: PCR Product Portfolio
Table 91: Hologic: News/Key Developments, Jan 2021-May 2023
Table 92: Merck KGaA: Company Snapshot
Table 93: Merck: Financials, 2022
Table 94: Merck: PCR Product Portfolio
Table 95: Qiagen: Company Snapshot
Table 96: Qiagen: Financials, 2022
Table 97: Qiagen: PCR Product Portfolio
Table 98: Qiagen: News/Key Developments, Jan 2021-May 2023
Table 99: Standard BioTools: Company Snapshot
Table 100: Standard BioTools: Financials, 2022
Table 101: Standard BioTools: PCR Product Portfolio
Table 102: Standard BioTools: Selected Key Developments, Jan 2021-July 2023
Table 103: Sysmex Inostics: Selected Key Developments, April 2020-July 2023
Table 104: Takara Bio Inc.: Company Snapshot
Table 105: Takara Bio Inc.: Financials, 2023
Table 106: Takara Bio Inc.: PCR Product Portfolio
Table 107: Takara Bio Inc.: News/Key Developments, Jan 2021-May 2023
Table 108: Thermo Fisher Scientific Inc.: Company Snapshot
Table 109: Thermo Fisher Scientific Inc.: Segment Information
Table 110: Thermo Fisher Scientific Inc.: Financials, 2022
Table 111: Thermo Fisher Scientific Inc.: PCR Portfolio
Table 112: Thermo Fisher Scientific Inc.: News/Key Developments, Jan 2021-July 2023
Table 113: Major Acronyms Used in This Report

List of Figures
Summary Figure A: Global Market for PCR, by Technique, 2020-2028
Summary Figure B: Global Market Shares of PCR, by Technique, 2022
Figure 1: Standard PCR Workflow
Figure 2: What the Pandemic Meant for IVD Companies: Key Trends
Figure 3: Regulatory Requirements for Laboratory Products
Figure 4: Advantages of Multiplex PCR
Figure 5: Advantages of Different PCR Methods
Figure 6: Global Market for PCR, by Technique, 2020-2028
Figure 7: Global Market Shares of PCR, by Technique, 2022
Figure 8: Global Market for PCR, by Product, 2020-2028
Figure 9: Global Market Shares of PCR, by Product, 2022
Figure 10: Global Market for PCR Instruments, by Type, 2020-2028
Figure 11: Global Market Shares of PCR Instruments, by Type, 2022
Figure 12: Global Market for PCR Reagents and Consumables, by Type, 2020-2028
Figure 13: Global Market Shares of PCR Reagents and Consumables, by Type, 2022
Figure 14: Global Market for PCR Software and Services, by Type, 2020-2028
Figure 15: Global Market Shares of PCR Software and Services, by Type, 2022
Figure 16: Global Market for PCR, by Application, 2020-2028
Figure 17: Global Market Shares of PCR, by Application, 2022
Figure 18: Global Market for PCR, by Region, 2020-2028
Figure 19: Global Market Shares of PCR, by Region, 2022
Figure 20: Benefits of a Strong ESG Proposition
Figure 21: Share of the Total U.S. Greenhouse Gas Emissions, by Economic Sector, 2021
Figure 22: Emerging Trends/Technologies in the PCR Market
Figure 23: PubMed Article Count: “Digital PCR (dPCR)”, 2010-2022
Figure 24: Point of Care Benefits
Figure 25: Share of “Polymerase chain reaction” or “PCR” Patents, by Assignee Country, 2020-2023*
Figure 26: PubMed Article Count: “RT-PCR” vs. “qPCR” vs. “dPCR” between 2010-2022
Figure 27: Abbott Laboratories: Financials, 2021 and 2022
Figure 28: Abbott Laboratories: Revenue Share, by Business Unit, 2022
Figure 29: Abbott Laboratories: Revenue Share, by Region, 2022
Figure 30: Agilent: Financials, 2021 and 2022
Figure 31: Agilent: Revenue Share, by Business Segment, 2022
Figure 32: Agilent: Revenue Share, by Region, 2022
Figure 33: BD: Financials, 2021 and 2022
Figure 34: BD: Market Share, by Segment, 2022
Figure 35: BD: Revenue Share, by Region, 2022
Figure 36: bioMérieux: Annual Revenue, 2021 and 2022
Figure 37: bioMérieux: Market Share, by Application Segment, 2022
Figure 38: bioMérieux: Revenue Share, by Region, 2022
Figure 39: Bio-Rad Laboratories Inc.: Financials, 2021 and 2022
Figure 40: Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2022
Figure 41: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
Figure 42: Danaher: Financials, 2021 and 2022
Figure 43: Danaher: Market Share, by Business Segment, 2022
Figure 44: Danaher: Revenue Share, by Region, 2022
Figure 45: Eppendorf: Financials, 2021 and 2022
Figure 46: Eppendorf: Market Share, by Business Division, 2022
Figure 47: Eppendorf: Revenue Share, by Region, 2022
Figure 48: Eurofins Scientific: Financials, 2021 and 2022
Figure 49: Eurofins Scientific: Market Share, by Major Service Lines, 2022
Figure 50: Eurofins Scientific: Revenue Share, by Region, 2022
Figure 51: Roche: Financials, 2021 and 2022
Figure 52: Roche: Market Share, by Business Segment, 2022
Figure 53: Hologic: Financials, 2021 and 2022
Figure 54: Hologic: Market Share, by Business Segment, 2022
Figure 55: Hologic: Revenue Share, by Region, 2022
Figure 56: Merck: Financials, 2021 and 2022
Figure 57: Merck: Market Share, by Business Segment, 2022
Figure 58: Merck: Revenue Share, by Region, 2022
Figure 59: Qiagen: Financials, 2021 and 2022
Figure 60: Qiagen: Market Share, by Product Group, 2022
Figure 61: Qiagen: Revenue Share, by Region, 2022
Figure 62: Standard BioTools: Financials, 2021 and 2022
Figure 63: Standard BioTools: Market Share, by Product Type, 2022
Figure 64: Standard BioTools: Revenue Share, by Region, 2022
Figure 65: Takara Bio Inc.: Annual Revenue, 2022 and 2023
Figure 66: Takara Bio Inc.: Market Share, by Business Segment, 2023
Figure 67: Takara Bio Inc.: Revenue Share, by Region, 2023
Figure 68: Thermo Fisher Scientific Inc.: Financials, 2021 and 2022
Figure 69: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
Figure 70: Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022

Executive Summary

PCR is a powerful molecular biology technique/tool. From diagnostics, research, and agriculture to forensics and environmental science, PCR techniques are an essential element in the arsenal of today’s scientists. Although the fundamental concept of PCR has remained unchanged over the years, novel PCR methods/protocols have continued to advance. With the recent inclination toward genomic and biomarker research and development, demands for advanced PCR technologies to study nucleic acid samples in greater detail have increased significantly.

During the COVID-19 period (2020 to 2022), quantitative real-time reverse transcription PCR (RT-qPCR) enabled widespread screening and rapid detection of the COVID-19 virus. Laboratories significantly expanded the installed equipment base and increased RT-qPCR testing capacity to meet the sharply increased demand. The global market for quantitative real-time PCR (qPCR) had reached around $17.1 billion in 2021, driven by significantly high demand for COVID-19 PCR tests. As the pandemic subsided in late 2022, the PCR market is expected to attain the pre-pandemic level and value around $9.1 billion in 2023. The market is projected to reach $12.6 billion and grow at a CAGR of 6.7% through 2028. Given the qPCR advantages over the endpoint PCR methods (higher sensitivity, specificity, speed, quantitative analysis, wider range of applications, etc.), the qPCR market is expected to grow rapidly in the next five years.

Multiplex PCR is a rapidly growing market. This market is expected to reach $2.4 billion through 2028, at a CAGR of 9.6% through the forecast period. The advantages of multiplex PCR in terms of efficiency, cost-effectiveness, time-savings, and data quality make it a valuable tool in molecular biology, genetics, clinical diagnostics, and many other fields.

dPCR is the fastest-growing PCR technology. Prized for the highly precise standard curve-free absolute quantification, dPCR is rapidly gaining momentum in research and clinical laboratories for absolute quantification of viral load, nucleic acid standards, NGS libraries, and gene expression.

Companies Mentioned

  • Abbott
  • Agilent Technologies, Inc.
  • Becton, Dickinson And Co.
  • Biomérieux
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Eppendorf Se
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Hologic
  • Merck Kgaa
  • Qiagen
  • Standard Biotools Inc.
  • Sysmex Inostics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table Information